Altogether, our findings are in line with previous reports in astrocytoma and breast cancer models that uncovered the need for RhoA activation to cycle in intensity and thus allow cell migration to occur [22, 23]. This evidence concerns the gene RHOA and astrocytoma (excluding glioblastoma).